The QCC app shows that Shanghai Runan Linghang Pharmaceutical Development Co., Ltd. was established, with Li He as the legal representative and a registered capital of 11 million yuan. The scope of operation includes: software development; import and export of goods; import and export agency; personal business services; tax services; government procurement agency services; conference and exhibition services; trade brokerage; offshore trade operations. QCC's equity trust penetration shows that the company is indirectly wholly-owned by Sino Biopharm.
中国生物制药于上海成立医药发展公司 含离岸贸易经营业务
Sino Biopharm established a pharmaceutical development company in Shanghai, including offshore trade operations.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.